Streetbeat News

Analyst Ratings

MRVL

Raymond James analyst Srini Pajjuri maintains an Outperform rating on Marvell Tech (NASDAQ:MRVL) and raises the price target from $50 to $64.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 12:11 pm

COST

In the last quarter, Costco Wholesale (NASDAQ:COST) received 2 bullish and 11 somewhat bullish ratings from 13 analysts, with an average 12-month price target of $545.15, a 1.53% decrease from the previous average price target of $553.60.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 12:11 pm

GDS

Raymond James analyst Frank Louthan maintains an Outperform rating on GDS Holdings (NASDAQ:GDS) but lowers the price target from $35 to $25.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 12:11 pm

STRA

Truist Securities analyst Tobey Sommer initiates coverage on Strategic Education (NASDAQ:STRA) with a Hold rating and announces a price target of $85.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:10 pm

TALO

Stephens & Co. analyst Mike Scialla reiterates an Overweight rating on Talos Energy (NYSE:TALO) and maintains a $21 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 12:10 pm

APEI

Truist Securities analyst Tobey Sommer initiates coverage on American Public Education (NASDAQ:APEI) with a Hold rating and announces a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:09 pm

UWMC

Over the past 3 months, 10 analysts have published their opinions on UWM Hldgs (NYSE:UWMC) stock, with an average price target of $4.78, implying a downside compared to the current price of $4.88. The current average has increased by 16.02% from the previous average price target of $4.12.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 12:08 pm

MDT

Truist Securities analyst Richard Newitter maintains a Hold rating on Medtronic (NYSE:MDT) and lowers the price target from $93 to $90.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:08 pm

AKBA

Akebia Therapeutics (NASDAQ:AKBA) has received 5 indifferent analyst ratings in the last quarter, with an average price target of $1.7, implying an upside from the current price of $1.21. The average price target has increased by 36.0% from the previous average of $1.25.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 12:08 pm

SRI

Stephens & Co. analyst Justin Long has reiterated an Overweight rating on Stoneridge (NYSE:SRI) and maintained a $23 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 12:07 pm